Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy

Treatment of multi-drug resistant Tuberculosis (MDR-TB) is challenging because it mostly relies on drugs with lower efficacy and greater toxicity than those used for drug-susceptible TB. Aim of the study was to describe the frequency and type of adverse drug reactions in a cohort of MDR-TB patients...

Full description

Saved in:

Bibliographic Details
Published in:	PloS one Vol. 14; no. 2; p. e0212948
Main Authors:	Gualano, Gina, Mencarini, Paola, Musso, Maria, Mosti, Silvia, Santangelo, Laura, Murachelli, Silvia, Cannas, Angela, Di Caro, Antonino, Navarra, Assunta, Goletti, Delia, Girardi, Enrico, Palmieri, Fabrizio
Format:	Journal Article
Language:	English
Published:	United States Public Library of Science 28.02.2019 Public Library of Science (PLoS)
Subjects:	Adult Adverse drug reactions Alcoholism Analysis Antitubercular agents Antitubercular Agents - adverse effects Antitubercular Agents - therapeutic use Biology and Life Sciences Central nervous system Cohort Studies Complications and side effects Dosage and administration Drug resistance Drug therapy Drug-Related Side Effects and Adverse Reactions - epidemiology Drugs Epidemiology Female Humans Italy - epidemiology Liver Male Medicine and Health Sciences Microbial drug resistance Microbiology Patient compliance Patient outcomes Prevalence studies (Epidemiology) Research and Analysis Methods Retrospective Studies Risk factors Substance abuse treatment Tertiary Care Centers Toxicity Treatment Failure Treatment Outcome Tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy Italy
ISSN:	1932-6203, 1932-6203
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!